Form 4 for HUMA Humacyte, Inc.
Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-24 · accession 0001818382-22-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-25 | 2022-05-24 | HUMA | Scheessele William John | Chief Commercial Off | P - Purchase | $4.72 | +10.5K | 10.5K | New | +$49.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-24 | P | A | 10,525 | $4.72 | 10,525 | D | — | — |